133 related articles for article (PubMed ID: 36608837)
21. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
22. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer].
Wang XH; Qian YM; Miao L; Le Y; Du J
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1003-5. PubMed ID: 27453113
[TBL] [Abstract][Full Text] [Related]
26. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.
Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N
Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222
[TBL] [Abstract][Full Text] [Related]
27. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
Li BH; Zhou JS; Ye F; Cheng XD; Zhou CY; Lu WG; Xie X
Eur J Cancer; 2011 Sep; 47(14):2166-74. PubMed ID: 21636267
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
30. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
Chen B; Zhao L; Yang R; Xu T
Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
[TBL] [Abstract][Full Text] [Related]
31. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
Pierry D; Weiss G; Lack B; Chen V; Fusco J
Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
[TBL] [Abstract][Full Text] [Related]
33. The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancer.
Wang J; Ding Z; Shu W; Zhuge Y
Cell Signal; 2023 Aug; 108():110728. PubMed ID: 37230198
[TBL] [Abstract][Full Text] [Related]
34. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
Wen N; Bian L; Gon J; Meng Y
Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
[TBL] [Abstract][Full Text] [Related]
35. Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.
Winer RL; Harris TG; Xi LF; Jansen KU; Hughes JP; Feng Q; Welebob C; Ho J; Lee SK; Carter JJ; Galloway DA; Kiviat NB; Koutsky LA
J Med Virol; 2009 Apr; 81(4):713-21. PubMed ID: 19235870
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
37. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
[TBL] [Abstract][Full Text] [Related]
38. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
[TBL] [Abstract][Full Text] [Related]
39. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
Liu H; Liang H; Li D; Wang M; Li Y
Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
[TBL] [Abstract][Full Text] [Related]
40. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]